According to Monopar Therapeutics's latest financial reports the company has $7.26 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $13.11 M | -35.38% |
2021-12-31 | $20.3 M | 21.31% |
2020-12-31 | $16.73 M | 26.66% |
2019-12-31 | $13.21 M | 91.71% |
2018-12-31 | $6.89 M | -23.26% |
2017-12-31 | $8.98 M | 333.36% |
2016-12-31 | $2.07 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 2,765.19% | ๐บ๐ธ USA |